Literature DB >> 14745457

Impairment of hepatic microcirculation in fatty liver.

Samia Ijaz1, Wenxuan Yang, Marc C Winslet, Alexander M Seifalian.   

Abstract

Fatty liver or hepatic steatosis, which is the result of the abnormal accumulation of triacylglycerol within the cytoplasm of hepatocytes, is a common histological finding in human liver biopsy specimens that is attributed to the effects of alcohol excess, obesity, diabetes, or drugs. There is a general consensus that fatty liver compromises hepatic microcirculation, the common exchange network upon which hepatic arterial and portal inflows converge, regardless of underlying etiology. A significant reduction in hepatic microcirculation has been observed in human fatty donor livers and in experimental models of hepatic steatosis. There is an inverse correlation between the degree of fat infiltration and both total hepatic blood flow and flow in microcirculation. Fatty accumulation in the cytoplasm of the hepatocytes is associated with an increase in the cell volume that reduces the size of the hepatic sinusoid space by 50% compared with a normal liver and may result in partial or complete obstruction of the hepatic sinusoid space. As a result of impaired hepatic microcirculation, the hepatocytes of the fatty liver have reduced tolerance against ischemia-reperfusion injury, which affects about 25% of the donors for liver transplantation because severe steatosis is associated with a high risk of primary nonfunction after liver transplantation.

Entities:  

Mesh:

Year:  2003        PMID: 14745457     DOI: 10.1038/sj.mn.7800206

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  46 in total

Review 1.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

Review 2.  Impact of obesity on chemotherapy management and outcomes in women with gynecologic malignancies.

Authors:  Neil S Horowitz; Alexi A Wright
Journal:  Gynecol Oncol       Date:  2015-04-12       Impact factor: 5.482

3.  The use of beta-adrenergic blockade in preventing trauma-induced hepatomegaly.

Authors:  Robert E Barrow; Robert R Wolfe; Mohan R Dasu; Laura N Barrow; David N Herndon
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

4.  The effect of hepatic ischemia reperfusion injury in a murine model of nonalcoholic steatohepatitis.

Authors:  Amit D Tevar; Callisia N Clarke; Rebecca Schuster; Jiang Wang; Michael J Edwards; Alex B Lentsch
Journal:  J Surg Res       Date:  2011-03-02       Impact factor: 2.192

5.  Contrast-Based Real-Time Assessment of Microcirculatory Changes in a Fatty Liver After Ischemia Reperfusion Injury.

Authors:  Vasantha L Kolachala; Rong Jiang; Carlos R Abramowsky; Nitika A Gupta
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-03       Impact factor: 2.839

Review 6.  Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease.

Authors:  Gyorgy Baffy
Journal:  Dig Dis Sci       Date:  2018-01-22       Impact factor: 3.199

7.  Mutual constraining of slow component and fast component measures: some observations in liver IVIM imaging.

Authors:  Yì Xiáng J Wáng
Journal:  Quant Imaging Med Surg       Date:  2021-06

8.  Type 2 diabetic patients with non-alcoholic fatty liver disease exhibit significant haemorheological abnormalities.

Authors:  Hui Dong; Fu'er Lu; Nan Wang; Xin Zou; Jingjing Rao
Journal:  Front Med       Date:  2011-10-02       Impact factor: 4.592

9.  Influence of Kupffer cells and platelets on ischemia-reperfusion injury in mild steatotic liver.

Authors:  Koichi Ogawa; Tadashi Kondo; Takafumi Tamura; Hideki Matsumura; Kiyoshi Fukunaga; Tatsuya Oda; Nobuhiro Ohkohchi
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

10.  Effects of donor steatosis on liver biochemistry and significance of body mass index in predicting steatosis.

Authors:  Rohan C Siriwardana; See Ching Chan; Kenneth S H Chok; Chung Mau Lo; Sheung Tat Fan
Journal:  HPB (Oxford)       Date:  2012-05-29       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.